CInMED MG Soft IPA Project

Year 1

Half-year 1

Half-year 2

Activity

1

2

3

4

5

6

7

8

9

10

11

12

1.1. Overall management activities

Dev 1.1

leader: CALIMS, participant: MG SOFT

1.2. Project coordination meetings

Dev 1.2

leader: CALIMS, participant: MG SOFT

1.3. Quality monitoring, assessment and control

Dev 1.3

leader: CALIMS, participant: MG SOFT

2.1. Development of Data Warehouse model for prescription of medicines in PHC IS

Dev 2.1

MG SOFT

2.2. Implementation of Data Warehouse for prescription of medicines in PHC IS

Dev 2.2

MG SOFT

2.3. Implementation and installation of Business Intelligence tools in CALIMS IS

MG SOFT

2.4. User training for BI for CALIMS professionals

Dev 2.4

MG SOFT

3.1. Analysis of obtained data on prescribing patterns of diclofenac in PHC (indications, administered dose, duration of therapy, medicines in concomitant use, comorbidities, contraindications, warnings and precautions)

Dev 3.1

CALIMS

3.2. Assessment of compliance or deviation of diclofenac prescribing in PHC with CALIMS and EMA recommendation of its safe use

Dev 3.2

CALIMS

3.3. Scientific research and statistical analysis of data with aim of publishing in relevant scientific journals

Dev 3.3

CALIMS

4.1. Definition of rules for messages and warnings in PHC.

MG SOFT

4.2. Development of SOAP Web service server on CALIMS IS side.

MG SOFT

4.3. Development of SOAP Web service client on PHC side.

MG SOFT

4.4. Upgrade of PHC IS for functionalities of medicine prescribing.

MG SOFT

4.5. Upgrade od CALIMS IS for setting up rules and monitoring of medicine prescribing.

MG SOFT

5.1. Scientific analysis of obtained data on prescribing patterns of diclofenac after imposing the restrictions of its use via information system

CALIMS

5.2. Assesment of compliance or deviation of diclofenac prescribing in PHC, after introduction of IT tools to rationalise its prescribing

CALIMS

5.3 Assessment of the effectiveness of the introduced new risk minimization measure (by CALIMS and MG SOFT) on the prescription and consumption of diclofenac in the PHC, in terms of the rationalisation in the consumption of diclofenac in Montenegro.

CALIMS

5.4. Scientific research and statistical analysis of data with the aim of publishing in relevant scientific journals

CALIMS

6.1. Dissemination Strategy and Exploitation Plan

Dev 6.1

leader: CALIMS, participant: MGSoft

6.2. Reports on dissemination activities (dissemmination of intermediate and final results)

Dev 6.2

leader: CALIMS, participant: MGSoft

6.3. Improvement of scientific and innovative capacity in CALIMS and MG SOFT

Dev 6.3

leader: CALIMS, participant: MGSoft

Year 2

Half-year 1

Half-year 2

Activity

1

2

3

4

5

6

7

8

9

10

11

12

1.1. Overall management activities

leader: CALIMS, participant: MG SOFT

1.2. Project coordination meetings

Dev 1.2

leader: CALIMS, participant: MG SOFT

1.3. Quality monitoring, assessment and control

Dev 1.3

leader: CALIMS, participant: MG SOFT

2.1. Development of Data Warehouse model for prescription of medicines in PHC IS

MG SOFT

2.2. Implementation of Data Warehouse for prescription of medicines in PHC IS

MG SOFT

2.3. Implementation and installation of Business Intelligence tools in CALIMS IS

MG SOFT

2.4. User training for BI for CALIMS professionals

MG SOFT

3.1. Analysis of obtained data on prescribing patterns of diclofenac in PHC (indications, administered dose, duration of therapy, medicines in concomitant use, comorbidities, contraindications, warnings and precautions)

CALIMS

3.2. Assessment of compliance or deviation of diclofenac prescribing in PHC with CALIMS and EMA recommendation of its safe use

CALIMS

3.3. Scientific research and statistical analysis of data with aim of publishing in relevant scientific journals

CALIMS

4.1. Definition of rules for messages and warnings in PHC.

Dev

4.1

MG SOFT

4.2. Development of SOAP Web service server on CALIMS IS side.

Dev

4.2

MG SOFT

4.3. Development of SOAP Web service client on PHC side.

Dev

4.3

MG SOFT

4.4. Upgrade of PHC IS for functionalities of medicine prescribing.

Dev

4.3

MG SOFT

4.5. Upgrade od CALIMS IS for setting up rules and monitoring of medicine prescribing.

Dev

4.3

MG SOFT

5.1. Scientific analysis of obtained data on prescribing patterns of diclofenac after imposing the restrictions of its use via information system

CALIMS

5.2. Assesment of compliance or deviation of diclofenac prescribing in PHC, after introduction of IT tools to rationalise its prescribing

CALIMS

5.3 Assessment of the effectiveness of the introduced new risk minimization measure (by CALIMS and MG SOFT) on the prescription and consumption of diclofenac in the PHC, in terms of the rationalisation in the consumption of diclofenac in Montenegro.

CALIMS

5.4. Scientific research and statistical analysis of data with the aim of publishing in relevant scientific journals

CALIMS

6.1. Dissemination Strategy and Exploitation Plan

Dev 6.1

leader: CALIMS, participant: MGSoft

6.2. Reports on dissemination activities (dissemmination of intermediate and final results)

Dev 6.2

leader: CALIMS, participant: MGSoft

6.3. Improvement of scientific and innovative capacity in CALIMS and MG SOFT

Dev 6.2

leader: CALIMS, participant: MGSoft

Year 3

Activity

1

2

3

4

5

6

7

8

1.1. Overall management activities

leader: CALIMS, participant: MG SOFT

1.2. Project coordination meetings

Dev 1.2

leader: CALIMS, participant: MG SOFT

1.3. Quality monitoring, assessment and control

Dev 1.3

leader: CALIMS, participant: MG SOFT

2.1. Development of Data Warehouse model for prescription of medicines in PHC IS

MG SOFT

2.2. Implementation of Data Warehouse for prescription of medicines in PHC IS

MG SOFT

2.3. Implementation and installation of Business Intelligence tools in CALIMS IS

MG SOFT

2.4. User training for BI for CALIMS professionals

MG SOFT

3.1. Analysis of obtained data on prescribing patterns of diclofenac in PHC (indications, administered dose, duration of therapy, medicines in concomitant use, comorbidities, contraindications, warnings and precautions)

CALIMS

3.2. Assessment of compliance or deviation of diclofenac prescribing in PHC with CALIMS and EMA recommendation of its safe use

CALIMS

3.3. Scientific research and statistical analysis of data with aim of publishing in relevant scientific journals

CALIMS

4.1. Definition of rules for messages and warnings in PHC.

MG SOFT

4.2. Development of SOAP Web service server on CALIMS IS side.

MG SOFT

4.3. Development of SOAP Web service client on PHC side.

MG SOFT

4.4. Upgrade of PHC IS for functionalities of medicine prescribing.

MG SOFT

4.5. Upgrade od CALIMS IS for setting up rules and monitoring of medicine prescribing.

MG SOFT

5.1. Scientific analysis of obtained data on prescribing patterns of diclofenac after imposing the restrictions of its use via information system

Dev 5.1

CALIMS

5.2. Assesment of compliance or deviation of diclofenac prescribing in PHC, after introduction of IT tools to rationalise its prescribing

Dev 5.2

CALIMS

5.3 Assessment of the effectiveness of the introduced new risk minimization measure (by CALIMS and MG SOFT) on the prescription and consumption of diclofenac in the PHC, in terms of the rationalisation in the consumption of diclofenac in Montenegro.